Crossmark

Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2016.07.006

Published Print: 2016-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Angulo, J.C.

Sánchez-Ballester, F.

Peral, C.

Rejas, J.

Ramos, J.

Snedecor, S.J.

Sudharshan, L.

Liu, S.

Luo, X.
License Information

Text and Data Mining valid from 2016-10-01
More Information

This article is maintained by: Elsevier

Article Title: Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2016.07.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2015.11.012

Content Type: article

Copyright: © 2016 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below